Skip to main content

Table 1 Association of ACBD3 with methylation sites in pan-cancers

From: Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study

CpG site

Cancer

Gene

Group

CpG Island

HR

CI

P

cg20786939

KIRC

ACBD3

TSS200

Island

0.362

(0.208;0.632)

 < 0.001

cg18385299

LGG

ACBD3

Body

N_Shore

0.382

(0.264;0.551)

 < 0.001

cg25844216

LGG

ACBD3

3'UTR

Open_Sea

0.573

(0.394;0.834)

0.004

cg15084160

PAAD

ACBD3

Body

N_Shelf

1.52

(1.014;2.281)

0.043

  1. HR hazard ratio, CI confidence interval, KIRC kidney renal clear cell carcinoma, LGG brain lower grade glioma, PAAD pancreatic adenocarcinoma
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us